Price (delayed)
$49.93
Market cap
$2.6B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.73
Enterprise value
$3.4B
NuVasive, Inc. is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes.
There are no recent dividends present for NUVA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.